Top Markets
#1 QuantixAI QuantixAI +102.23%
#2 Pons Pons +31.77%
#3 龙虾 (Lobster) 龙虾 (Lobster) +31.60%
#4 Rain Rain +30.90%
#5 MetaDAO MetaDAO +27.67%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +24.74%
#7 Bedrock Bedrock +20.57%
#8 Ontology Gas Ontology Gas +18.03%
#9 Prom Prom +18.01%
#10 peaq peaq +16.66%
Coin of the day
QuantixAI QuantixAI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Clasificación en acciones #20256
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Precio por acción
$1.90
Capitalización bursátil
$135.79M
Cambio (1 día)
-0.50%
Cambio (1 año)
20.89%
País
TW
Comercio Sinew Pharma Inc. (6634)

Categoría

Healthcare
Ratio P/B de Sinew Pharma Inc. (6634)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Sinew Pharma Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Sinew Pharma Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH